Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC29A1 | Q99808 | 2/20 | 0.42 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.39 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.39 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.39 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28475028 | 0.88 | SLC29A1 (0.46) | SLC29A1ADORA1ADORA2AADORA2BADORA3 | |
| SCHEMBL219553 | 0.85 | ADORA3 (0.49) | SLC29A1ADORA1ADORA2AADORA2BADORA3 | |
| SCHEMBL17627818 | 0.83 | RXFP1 (0.39) | SLC29A1ADORA1ADORA2AADORA2BADORA3 | |
| SCHEMBL30705001 | 0.83 | RXFP1 (0.39) | SLC29A1ADORA1ADORA2AADORA2BADORA3 | |
| SCHEMBL27455665 | 0.83 | PI4KA (0.39) | SLC29A1ADORA1ADORA2AADORA2BADORA3 | |
| SCHEMBL29435121 | 0.82 | TARS1 (0.38) | SLC29A1ADORA1 | |
| SCHEMBL16987222 | 0.82 | TARS1 (0.38) | SLC29A1ADORA1 | |
| SCHEMBL28564130 | 0.82 | TARS1 (0.38) | SLC29A1ADORA1 | |
| Phosphoric Acid SCHEMBL474409 | 0.81 | ADORA1 (0.48) | SLC29A1ADORA1ADORA2AADORA2BADORA3 | |
| Acetaldehyde SCHEMBL27678170 | 0.81 | ADORA3 (0.48) | SLC29A1ADORA1ADORA2AADORA2BADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109563127-B | Compounds, agents and uses thereof | 麦特博隆股份有限公司 | 2024-01-05 | — | — | CN | disclosed |